Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wonbiogen is a South Korean biotechnology and medical device company specializing in advanced wound care and skin regeneration solutions. The company develops and manufactures a diverse portfolio of functional dressings, including hydrocolloids, polyurethane foams, and silicone-based products designed to accelerate the healing of chronic and acute wounds. Beyond traditional wound care, Wonbiogen leverages its proprietary medical polymer technology to develop innovative drug delivery systems and functional cosmetics. Their products are utilized globally across clinical settings for treating surgical incisions, burns, and ulcers. The company is committed to advancing dermatological health through continuous research into biocompatible materials and tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wonbiogene.